| 公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
1 | 2024 | Curcumin-derived carbon quantum dots: Dual actions in mitigating tau hyperphosphorylation and amyloid beta aggregation | Lim, Jie Lay; Lin, Chin-Jung; Huang, Chih-Ching; LIN-CHAU CHANG | Colloids and surfaces. B, Biointerfaces | | | |
2 | 2024 | Enhancing the identification of voriconazole-associated hepatotoxicity by targeted metabolomics | Chiang, Yi-Hsuan; Cheng, Chih-Ning; Chuang, Pei-Jiun; YEE-CHUN CHEN ; Chen, Yi-Jing; CHING-HUA KUO ; SHU-WEN LIN ; LIN-CHAU CHANG | International journal of antimicrobial agents | 0 | 0 | |
3 | 2023 | Investigation of Immunogenicity Assessment of Biosimilar Monoclonal Antibodies in the United States | Cheng, Ching-An; Jiang, Ai-Lei; Liu, Yu-Ru; LIN-CHAU CHANG | Clinical pharmacology and therapeutics | | | |
4 | 2023 | Regulatory considerations for generic products of non-biological complex drugs | Liu, Yu-Hsuan; Chen, Yi-Shuo; Tseng, Ting; Jiang, Min-Lin; Gau, Churn-Shiouh; LIN-CHAU CHANG | Journal of food and drug analysis | 1 | 1 | |
5 | 2022 | Orphan drug development: The impact of regulatory and reimbursement frameworks | Huang, Yu-Jun; Chao, Wan-Yu; CHI-CHUAN WANG ; LIN-CHAU CHANG | Drug discovery today | 2 | 1 | |
6 | 2022 | Corrigendum to “The impact of the rare disease and Orphan Drug Act in Taiwan” [J Food Drug Anal 29 (2021) 717e725] | Hsiang, Ning Chun; Huang, Weng Foung; Gau, Churn Shiouh; Tsai, Teng Wen; LIN-CHAU CHANG | Journal of Food and Drug Analysis | 0 | 0 | |
7 | 2021 | The impact of the rare disease and Orphan Drug Act in Taiwan | Hsiang, Ning-Chun; Huang, Weng-Foung; Gau, Churn-Shiouh; Tsai, Teng-Wen; LIN-CHAU CHANG | Journal of food and drug analysis | 1 | 2 | |
8 | 2021 | Investigation of Factors Associated With Immunogenicity Labeling Updates and Characteristics of Biologics License Applications | Jiang, Ai-Lei; Breder, Christopher D; LIN-CHAU CHANG | Clinical pharmacology and therapeutics | 1 | 1 | |
9 | 2021 | Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel | Huang J.-W.; CHING-HUA KUO ; Kuo H.-C.; JIN-YUAN SHIH ; Tsai T.-W.; LIN-CHAU CHANG | PLoS ONE | 6 | 4 | |
10 | 2021 | Differences in Fatty Acid Oxidation between Nab-Paclitaxel- And Solvent-Based Paclitaxel-Treated A549 Cells Based on Metabolomics | Huang J.-W.; CHING-HUA KUO ; Kuo H.-C.; JIN-YUAN SHIH ; Tsai T.-W.; LIN-CHAU CHANG | ACS Omega | 2 | 2 | |
11 | 2019 | Improved Dried Blood Spot-Based Metabolomics Analysis by a Postcolumn Infused-Internal Standard Assisted Liquid Chromatography-Electrospray Ionization Mass Spectrometry Method | Chepyala, Divyabharathi; Kuo, Han Chun; KANG-YI SU ; Liao, Hsiao Wei; Wang, San Yuan; Chepyala, Surendhar Reddy; LIN-CHAU CHANG ; CHING-HUA KUO | Analytical Chemistry | 14 | 10 | |
12 | 2019 | Evaluation and Optimization of Sample Handling Methods for Quantification of Short-Chain Fatty Acids in Human Fecal Samples by GC-MS | Hsu, Ya-Lin; CHIEH-CHANG CHEN ; Lin, Ya-Ting; WEI-KAI WU ; LIN-CHAU CHANG ; Lai, Chang-Hao; MING-SHIANG WU ; CHING-HUA KUO | Journal of proteome research | 60 | 47 | |
13 | 2019 | Correlates of time to approval and other clinical development periods | Breder C.D.; VanHeusen M.; LIN-CHAU CHANG | Drug Discovery Today | 0 | 0 | |
14 | 2019 | Investigation of quality review issues and the association with application characteristics for new drug applications in first-cycle reviews | Liou J.-S.; LIN-CHAU CHANG | Regulatory Toxicology and Pharmacology | 0 | 0 | |
15 | 2019 | The biosimilar pathway in the USA: An analysis of the innovator company and biosimilar company perspectives and beyond | LIN-CHAU CHANG | Journal of Food and Drug Analysis | 5 | 4 | |
16 | 2019 | Identification of factors associated with first-cycle drug approval rates and regulatory outcomes for new drug applications | LIN-CHAU CHANG ; Vanheusen M.; Fang X.; Breder C.D. | Pharmacological Research | 3 | 3 | |
17 | 2018 | Thyrotropin receptor antibodies and a genetic hint in antithyroid drug-induced adverse drug reactions | LIN-CHAU CHANG ; Chang C.-C.; PEI-LUNG CHEN ; Wang S.-H.; Chen Y.-H.; Tsai Y.-H.; SHYANG-RONG SHIH ; WEI-YIH CHIU ; Fann C.S.-J.; WEI-SHIUNG YANG ; TIEN-CHUN CHANG | Expert Opinion on Drug Safety | 5 | 5 | |
18 | 2018 | Recent updates and challenges on the regulation of precision medicine: The United States in perspective | LIN-CHAU CHANG ; Colonna T.E. | Regulatory Toxicology and Pharmacology | 1 | 0 | |
19 | 2018 | Prognostic factors in epithelial ovarian cancer: A population-based study | LIN-CHAU CHANG ; CHIH-FEN HUANG ; Lai M.-S.; LI-JIUAN SHEN ; FE-LIN LIN WU ; WEN-FANG CHENG | PLoS ONE | 64 | 56 | |
20 | 2017 | Patterns of use and impact of standardised MedDRA query analyses on the safety evaluation and review of new drug and biologics license applications | LIN-CHAU CHANG ; Mahmood R.; Qureshi S.; Breder C.D. | PLoS ONE | 11 | 10 | |
21 | 2016 | Development of the risk-based, phased-in approach for the international harmonization of the regulation of container closure systems for drugs in Taiwan | LIN-CHAU CHANG ; Kang J.-J.; Gau C.-S. | Regulatory Toxicology and Pharmacology | 3 | 2 | |
22 | 2015 | The evolution and challenges for the international harmonization of the regulation of pharmaceutical excipients in Taiwan | LIN-CHAU CHANG ; Kang J.-J.; Gau C.-S. | Regulatory Toxicology and Pharmacology | 4 | 2 | |
23 | 2013 | Statistics, Quality Review Issues, and Beyond for Generic Drug Applications in Taiwan | LIN-CHAU CHANG ; Gau C.-S. | Therapeutic Innovation and Regulatory Science | 5 | 5 | |
24 | 2009 | The clinical implications of blood adiponectin in cardiometabolic disorders | LIN-CHAU CHANG ; KUO-CHIN HUANG ; YEN-WEN WU ; HSIEN-LI KAO ; CHI-LING CHEN ; LING-PING LAI ; HWANG, JUEY-JEN ; WEI-SHIUNG YANG | Journal of the Formosan Medical Association | 54 | 49 | |
25 | 2008 | Determining Estrogens Using Surface-Assisted Laser Desorption/Ionization Mass Spectrometry with Silver Nanoparticles as the Matrix | Chiu, Tai-Chia; LIN-CHAU CHANG ; Chiang, Cheng-Kang; HUAN-TSUNG CHANG | Journal of the American Society for Mass Spectrometry | 86 | 79 | |
26 | 2008 | Interfacial properties of Pluronics and the interactions between Pluronics and cholesterol/DPPC mixed monolayers | LIN-CHAU CHANG ; Chang Y.-Y.; Gau C.-S. | Journal of Colloid and Interface Science | 39 | 38 | |
27 | 2008 | Adiponectin: A biomarker of obesity-induced insulin resistance in adipose tissue and beyond | JIN-YING LU ; KUO-CHIN HUANG ; LIN-CHAU CHANG ; Huang Y.-S.; Chi Y.-C.; Su T.-C.; CHI-LING CHEN ; WEI-SHIUNG YANG | Journal of Biomedical Science | 88 | 87 | |
28 | 2008 | Simultaneous separation of four types of steroid hormones by micellar electrokinetic chromatography with cetyltrimethylammonium bromide | LIN-CHAU CHANG ; Chiu T.-C.; SHOEI-SHENG LEE ; CHING-HUA KUO ; TIEN-CHUN CHANG | Journal of the Chinese Chemical Society | 3 | 3 | |
29 | 2006 | Cyclodextrin-modified microemulsion electrokinetic chromatography for separation of α-, γ-, δ-tocopherol and α-tocopherol acetate | Chang, Lin-Chau ; Chang, Huan-Tsung ; Sun, Shao-Wen | Journal of Chromatography A | 28 | 25 | |
30 | 2006 | Micellar electrokinetic chromatography for separation of a mixture of coptis alkaloids, scute flavonoids, and rhubarb anthraquinones and bianthrones | LIN-CHAU CHANG ; Sun S.-W. | Journal of Pharmaceutical and Biomedical Analysis | 36 | 32 | |
31 | 2005 | Interactions of Pluronics with phospholipid monolayers at the air-water interface | LIN-CHAU CHANG ; Lin C.-Y.; Kuo M.-W.; Gau C.-S. | Journal of Colloid and Interface Science | 44 | 45 | |